| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.035 | 0.5 |